Can We Relieve Auditory Hallucinations in Victims of Schizophrenia With Computer Generated Avatars?

Scientists are studying the potential benefits of computer-generated avatars in helping patients with schizophrenia combat auditory hallucinations.

Hearing voices is a common symptom in victims of schizophrenia. Often these voices are rude and frightening. In this study, the researchers evaluated the effectiveness of using avatars to help victims combat abusive and rude voices in their head, especially in patients where medications were not effective.

Schizophrenia Symptoms Eliminated in Mice Model
Scientists have shown in mice models that overexpression of a gene associated with schizophrenia causes classic symptoms of the disorder that are reversed when gene expression returns to normal.

During the study, the subjects had to create an avatar, which is a computer generated face with a voice closely resembling the hallucinated voice. They were asked to confront and challenge the avatar, controlled by the therapist.

This study showed that avatar therapy was effective in patients compared to those who continued to receive standard treatment for schizophrenia (antipsychotic medication).

The results were very encouraging, some of the victims hearing such voices for more than 15 years, found that the voice just disappeared after two sessions. More research in this area is needed to use avatar therapy to treat auditory hallucinations in victims of schizophrenia.

Rare Genetic Mutations Team Up To Cause Schizophrenia: Family Studies
Researchers at Johns Hopkins have found that individually harmless genetic variations affecting related biochemical processes may team up to increase the risk of schizophrenia.

Source-Medindia

Lead Acts to Trigger Schizophrenia: Scientists
Behaviors and structural changes in the brain consistent with schizophrenia was exhibited by mice who were engineered with a human gene for schizophrenia.

How Old Schizophrenia Medicine Works Against Antibiotic Resistant Bacteria-Explained
Research shows that the drug previously used to treat schizophrenia is a powerful weapon against antibiotic-resistant bacteria